RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration. - Wikidata - wikimedia - TriplyDB

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

http://www.wikidata.org/entity/Q35156007

about

Gene, Stem Cell, and Alternative Therapies for SCA 1 Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia.Adoptive transfer of immune cells from glaucomatous mice provokes retinal ganglion cell loss in recipients.Mutant CAG Repeats Effectively Targeted by RNA Interference in SCA7 Cells.Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts.Knockdown and replacement therapy mediated by artificial mirtrons in spinocerebellar ataxia 7.Time Is Cerebellum.

P2860

Q26738497-D773E243-C81E-48FC-9898-FC333E5D1E0A Q34499502-B2E1E4AE-35A5-4894-B1CA-062088C1AC40 Q36114710-D210041C-03B8-4414-BEAE-0A87B2F53519 Q37539531-8081E860-3E99-46BF-B432-A3EBA0D0B9F2 Q38792714-05519CD9-4D3B-479C-9DE4-C8782DFC9E15 Q41508524-C6342035-47E1-4DC4-ADB8-CEC47D03961C Q49824844-5D83F929-3B4E-479E-B5D9-8EE6CE7BEBDB

P2860

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

http://www.wikidata.org/entity/Q35156007

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

@ast

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

@en

type

label

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

@ast

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

@en

prefLabel

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

@ast

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration.

@en

P1433

Q35156007-2974A211-9EA7-47D7-8F6D-3683E60ECC3F

P1476

Q35156007-B7CD1525-B958-497C-89C0-C2787125D79F

P2093

Q35156007-2237EBFF-7FA2-4B4A-A590-E2D86512B0E1

Q35156007-C41554B8-DD6D-49A7-886A-EA97757739FA

Q35156007-C48E3360-24C2-48AD-91AC-995A60C48FB3

Q35156007-EA954EBA-862E-4C44-9101-3A8BE2416BC1

Q35156007-FC698A3B-99EC-4337-977E-C0FAE5F79BF2

P2860

Q35156007-17BDE350-21E3-4E68-9F81-9B6890C9B8FE

Q35156007-223F0D0E-EB92-47FE-8804-E03444E9F640

Q35156007-22C8202B-AF0C-4BB4-AA3E-70DBDA5E4FBC

Q35156007-34329342-3ABA-47AD-A4D8-BF1DE57CF8A5

Q35156007-39DB17D7-81EC-4F7C-A2D9-FD1B77EC2B14

Q35156007-40A290D8-8CEF-4661-AEDE-1B7BBAF1D214

Q35156007-469648A7-2204-4BC3-9B1A-43EBB37E14CB

Q35156007-53694897-12F4-46C5-97E9-53DD9DB68F62

Q35156007-62D70903-1A45-45BD-81AB-719BAE1751CE

Q35156007-69E9A379-3109-4591-BC09-0F8CDBDC2EE8

P304

Q35156007-E31545C1-79A5-460B-8D5E-20F360B5383D

P31

Q35156007-DDDD6AD7-BBF8-435A-B8F2-6D073858DCDB

P356

Q35156007-25067AC9-D559-44AE-9A32-79F4F0ABF784

P407

Q35156007-D00403B7-5DFE-463B-9E9B-1D8E2CD8E339

P433

Q35156007-457FDD96-6461-4A68-A5AB-5B1F0A80E46F

P478

Q35156007-5BA43C52-17C6-441A-86DA-B1E98ECDD606

P50

Q35156007-0951618F-28A0-4D72-AC92-E53514C945A7

Q35156007-10220929-CABA-4522-AE60-DA916A2A3253

Q35156007-ECB9C186-413A-4112-A1A1-87A61ED9A11D

P577

Q35156007-0C04FEB9-9165-43AB-84A3-B48BE7646697

P5875

Q35156007-8E39B05F-377E-45B7-B8F2-A29DA5A31A2F

P698

Q35156007-B2842BF1-C614-4BC1-A16D-FEBB72E03957

P932

Q35156007-9AD8F927-44C7-47BB-BEDA-708A27DFBD42

P356

JOURNAL.PONE.0095362

P1433

P1476

RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration

@en

P2093

Albert R Laspada

http://www.w3.org/2001/XMLSchema#string

Beverly L Davidson

http://www.w3.org/2001/XMLSchema#string

Pavitra S Ramachandran

http://www.w3.org/2001/XMLSchema#string

Pratibha Singh

http://www.w3.org/2001/XMLSchema#string

Sajag Bhattarai

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of an expanded ataxia interactome with patient medical records reveals a relationship between macular degeneration and ataxia

Real-time quantification of microRNAs by stem-loop RT-PCR

Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7

Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system

Non-viral siRNA delivery into the mouse retina in vivo.

Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in vitro and in vivo.

Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.

Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.

Optogenetic therapy for retinitis pigmentosa.

RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1

P304

e95362

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0095362

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Ryan L. Boudreau

Stewart Thompson

P577

2014-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261838256

http://www.w3.org/2001/XMLSchema#string

P698

24759684

http://www.w3.org/2001/XMLSchema#string

P932

3997397

http://www.w3.org/2001/XMLSchema#string